AC

Anila Chandak

Active Director Director DIN 09464494
DIN 09464494 First appointment Jun 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Anila Chandak

Data last updated:

Anila Chandak is a Director at Doctors Pharmaceuticals Private Limited (since 2022). The company operates in Healthcare. Doctors Pharmaceuticals Private Limited reported revenue of ₹13 Lakh (FY 2025).

DIN 09464494
Primary Designation Director
Industry Healthcare
First Appointment 01 Jun 2022
Oldest Company Age 50 yrs
Largest company Doctors Pharmaceuticals Private Limited · ₹13 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20221976₹13 Lakh (FY 2025)Active

Board colleagues of Anila Chandak

Directorship timeline

Open interactive timeline →
Doctors Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anila Chandak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anila Chandak

Anila Chandak currently holds 1 directorship: Doctors Pharmaceuticals Private Limited (Director, since 01 Jun 2022, revenue ₹13 Lakh (FY 2025)).

Anila Chandak was first appointed on 01 Jun 2022 as Director at Doctors Pharmaceuticals Private Limited.

The current boards of Anila Chandak's companies include Krishna Gopal Srivastava (Doctors Pharmaceuticals Private Limited), Nikhil Chandak (Doctors Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available